http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201992142-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1682
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1641
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1611
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513
filingDate 2018-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-201992142-A1
titleOfInvention PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATIONS
abstract The present invention provides pharmaceutical compositions that can be used to treat and / or prevent a disorder such as addiction. For example, pharmaceutical compositions are provided that comprise a first active pharmaceutical ingredient (eg metirapone) and a second active pharmaceutical ingredient (eg oxazepam). These compositions can be designed in such a way that there will be limited physical contact between the first and second active pharmaceutical ingredients, preventing degradation of the active pharmaceutical ingredients due to the interaction of these two components. The compositions can contain at least one pharmaceutically acceptable excipient. Also proposed are methods for preparing the compositions, as well as kits containing substances that provide the use of these compositions.
priorityDate 2017-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525482
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4616

Total number of triples: 27.